778 related articles for article (PubMed ID: 10091734)
1. Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation.
Koc Y; Miller KB; Schenkein DP; Daoust P; Sprague K; Berkman E
Cancer; 1999 Feb; 85(3):608-15. PubMed ID: 10091734
[TBL] [Abstract][Full Text] [Related]
2. Case report of spontaneous remission of cytogenetic relapse of chronic myelogenous leukemia suggestive of progression to blast crisis after allogeneic bone marrow transplantation.
Agaliotis DP; Papenhausen PR; Moscinski LC; Elfenbein GJ
Ann Hematol; 1995 Jan; 70(1):37-41. PubMed ID: 7827205
[TBL] [Abstract][Full Text] [Related]
3. Localized lymphoid relapse in the pancreas following allogeneic hematopoietic stem cell transplant for chronic myelogenous leukemia.
Rossetti JM; Lister J; Shadduck RK; Bloom E; Geyer SJ; Caushaj PF; Homann J; Papasavas P; Cedar M
Leuk Lymphoma; 2003 Jun; 44(6):1071-4. PubMed ID: 12854913
[TBL] [Abstract][Full Text] [Related]
4. A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
Elmaagacli AH; Beelen DW; Schaefer UW
Bone Marrow Transplant; 1997 Dec; 20(12):1045-55. PubMed ID: 9466277
[TBL] [Abstract][Full Text] [Related]
5. Repeated relapses of acute myelogenous leukemia in the isolated extramedullary sites following allogeneic bone marrow transplantations.
Kikushige Y; Takase K; Sata K; Aoki K; Numata A; Miyamoto T; Fukuda T; Gondo H; Harada M; Nagafuji K
Intern Med; 2007; 46(13):1011-4. PubMed ID: 17603242
[TBL] [Abstract][Full Text] [Related]
6. Induction of molecular remission by donor peripheral blood leukocyte therapy in patients relapsing with extramedullary blastic phase chronic myeloid leukemia after allogeneic bone marrow transplantation.
Bashey A; Shepherd S; Frankel W; Wang-Rodriguez J; Cahill T; Chamberlain M; Mason JR; Ho AD; Corringham RE
Oncol Rep; 1998; 5(1):281-5. PubMed ID: 9458334
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
[TBL] [Abstract][Full Text] [Related]
8. Autologous bone marrow transplantation in acute myeloid leukemia in first remission: results of a Dutch prospective study.
Löwenberg B; Verdonck LJ; Dekker AW; Willemze R; Zwaan FE; de Planque M; Abels J; Sonneveld P; van der Lelie J; Goudsmit R
J Clin Oncol; 1990 Feb; 8(2):287-94. PubMed ID: 2405106
[TBL] [Abstract][Full Text] [Related]
9. Isolated extramedullary relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia.
Au WY; Chan AC; Lie AK; So JC; Liang R; Kwong YL
Bone Marrow Transplant; 1998 Jul; 22(1):99-102. PubMed ID: 9678803
[TBL] [Abstract][Full Text] [Related]
10. [Allogeneic bone marrow transplantation in myeloid leukemia: chemical conditioning, clinical course and results].
Glejzer O; Sedzimirska M; Tomaszewska-Toporska B; Tomeczko J; Kołodziej J; Pacuszko T; Was A; Bocheńska J; Jaźwiec B; Klimczak A
Acta Haematol Pol; 1992; 23(2 Suppl 1):49-59. PubMed ID: 1488872
[TBL] [Abstract][Full Text] [Related]
11. Isolated testicular and bone relapse in children with acute myeloblastic leukemia and chronic graft versus host disease after allogeneic BMT.
Yildirim I; Uçkan D; Cetin M; Tuncer M; Tezcan I
Turk J Pediatr; 2007; 49(2):206-9. PubMed ID: 17907524
[TBL] [Abstract][Full Text] [Related]
12. Importance of mixed chimerism to predict relapse in persistently BCR/ABL positive long survivors after allogeneic bone marrow transplantation for chronic myeloid leukemia.
Román J; Martín C; Torres A; García A; Andrés P; García MJ; Baiget M
Leuk Lymphoma; 1998 Feb; 28(5-6):541-50. PubMed ID: 9613984
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation.
Román J; Alvarez MA; Torres A
Haematologica; 2000 Oct; 85(10):1072-82. PubMed ID: 11025600
[TBL] [Abstract][Full Text] [Related]
14. [Chronic myeloid leukemia relapsing ten years after allogenic bone marrow transplantation].
Hino Y; Doki N; Yamamoto K; Senoo Y; Sasajima S; Sakaguchi M; Hattori K; Kaito S; Kurosawa S; Harada K; Ikegawa S; Watanabe D; Hagino T; Yoshioka K; Watakabe K; Igarashi A; Najima Y; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
Rinsho Ketsueki; 2016 May; 57(5):608-12. PubMed ID: 27263786
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow transplantation for children with acute myelogenous leukaemia in the first complete remission.
Matsuyama T; Horibe K; Kato K; Kojima SS
Eur J Cancer; 2000 Feb; 36(3):368-75. PubMed ID: 10708939
[TBL] [Abstract][Full Text] [Related]
16. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
[TBL] [Abstract][Full Text] [Related]
17. Leukemia: management of relapse after allogeneic bone marrow transplantation.
Kumar L
J Clin Oncol; 1994 Aug; 12(8):1710-7. PubMed ID: 8040682
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
19. Outcome of Chinese patients with chronic myeloid leukaemia (CML) underwent allogeneic bone-marrow transplantation (BMT).
Lee CK; Lie AK; Liang R; Au WY; Chen FE; Chim CS; Kwong YL
Am J Hematol; 1999 Jun; 61(2):85-9. PubMed ID: 10367784
[TBL] [Abstract][Full Text] [Related]
20. Relapse in chronic myeloid leukemia after bone marrow transplantation: biomathematical modeling as a new approach to understanding pathogenesis.
Vincent PC; Rutzen-Loesevitz L; Tibken B; Heinze B; Hofer EP; Fliedner TM
Stem Cells; 1999; 17(1):9-17. PubMed ID: 10215403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]